NanoViricides (NNVC) Stock Chart & Stock Price History $1.26 -0.02 (-1.56%) As of 02:23 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock NanoViricides Stock Price Performance The NanoViricides (NNVC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 30.77%, with a year-to-date return of -11.89%. In the past month, the stock has increased 13.51%, reflecting recent market activity. As of the latest close, NanoViricides traded at $1.28 with a market cap of $20.04 million and volume of 72,153 shares. Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.64%1 Month Performance+13.51%3 Month Performance-2.33%Year-To-Date Performance-11.89%1 Year Performance-30.77% NNVC Stock Chart for Tuesday, May, 13, 2025 NNVC Chart by TradingView NanoViricides Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/12/2025$1.32$1.28-2.95%$1.32$1.2572,153 shs$20.04 million05/09/2025$1.41$1.32-6.38%$1.44$1.28118,881 shs$20.65 million05/08/2025$1.24$1.41+14.17%$1.45$1.26385,585 shs$22.05 million05/07/2025$1.31$1.24-5.73%$1.29$1.2059,128 shs$19.32 million05/06/2025$1.25$1.31+4.59%$1.28$1.2514,729 shs$20.49 million05/05/2025$1.30$1.25-3.65%$1.33$1.2538,368 shs$19.59 million05/02/2025$1.33$1.30-2.26%$1.37$1.2785,979 shs$20.33 million05/01/2025$1.37$1.33-2.92%$1.40$1.3082,360 shs$20.80 million04/30/2025$1.34$1.37+2.24%$1.42$1.3594,941 shs$21.43 million04/29/2025$1.35$1.34-0.37%$1.36$1.3139,792 shs$20.96 million Get the Latest News and Ratings for NNVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. 04/28/2025$1.42$1.35-5.28%$1.42$1.3259,549 shs$21.04 million04/25/2025$1.35$1.42+5.19%$1.42$1.37113,018 shs$22.21 million04/24/2025$1.33$1.35+1.20%$1.37$1.3339,972 shs$21.12 million04/23/2025$1.34$1.33-0.45%$1.39$1.3051,902 shs$20.87 million04/22/2025$1.30$1.34+3.08%$1.37$1.3040,149 shs$20.96 million04/21/2025$1.33$1.30-2.26%$1.38$1.30104,566 shs$20.33 million04/18/2025$1.33$1.33$1.35$1.25106,855 shs$20.80 million04/17/2025$1.40$1.33-5.00%$1.35$1.25106,855 shs$20.80 million04/16/2025$1.33$1.40+5.26%$1.48$1.34325,322 shs$21.90 million04/15/2025$1.19$1.33+11.76%$1.33$1.15181,255 shs$20.80 million04/14/2025$1.11$1.19+7.21%$1.20$1.09177,042 shs$18.61 million Related Companies Adaptimmune Therapeutics Stock Price Chart Unicycive Therapeutics Stock Price Chart CytomX Therapeutics Stock Price Chart Elutia Stock Price Chart Cassava Sciences Stock Price Chart IGM Biosciences Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Adagene Stock Price Chart Genenta Science Stock Price Chart ESSA Pharma Stock Price Chart Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NNVC) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.